Cargando…

A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus

AIMS/HYPOTHESIS: Homozygosity for a five leucine repeat (5L–5L) in the carnosinase gene (CNDP1) has been found to be cross-sectionally associated with a low frequency of diabetic nephropathy (DN), mainly in type 2 diabetes. We prospectively investigated in patients with type 1 diabetes whether: (1)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alkhalaf, A., Bakker, S. J. L., Bilo, H. J. G., Gans, R. O. B., Navis, G. J., Postmus, D., Forsblom, C., Groop, P. H., Vionnet, N., Hadjadj, S., Marre, M., Parving, H. H., Rossing, P., Tarnow, L.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2974933/ https://www.ncbi.nlm.nih.gov/pubmed/20711718 http://dx.doi.org/10.1007/s00125-010-1863-0

Ejemplares similares

Serum Carnosinase-1 and Albuminuria Rather than the CNDP1 Genotype Correlate with Urinary Carnosinase-1 in Diabetic and Nondiabetic Patients with Chronic Kidney Disease
por: Rodriguez-Niño, Angelica, et al.
Publicado: (2019)

Exclusion of Polymorphisms in Carnosinase Genes (CNDP1 and CNDP2) as a Cause of Diabetic Nephropathy in Type 1 Diabetes: Results of Large Case-Control and Follow-Up Studies
por: Wanic, Krzysztof, et al.
Publicado: (2008)

Association Between CNDP1 Genotype and Diabetic Nephropathy Is Sex Specific
por: Mooyaart, Antien L., et al.
Publicado: (2010)

Novel Susceptibility Locus at 22q11 for Diabetic Nephropathy in Type 1 Diabetes
por: Wessman, Maija, et al.
Publicado: (2011)

G/T Substitution in Intron 1 of the UNC13B Gene Is Associated With Increased Risk of Nephropathy in Patients With Type 1 Diabetes
por: Trégouet, David-Alexandre, et al.
Publicado: (2008)

Serum Uric Acid as a Predictor for Development of Diabetic Nephropathy in Type 1 Diabetes: An Inception Cohort Study
por: Hovind, Peter, et al.
Publicado: (2009)

Effect of Benfotiamine on Advanced Glycation Endproducts and Markers of Endothelial Dysfunction and Inflammation in Diabetic Nephropathy
por: Alkhalaf, Alaa, et al.
Publicado: (2012)

Functional annotations of diabetes nephropathy susceptibility loci through analysis of genome-wide renal gene expression in rat models of diabetes mellitus
por: Hu, Yaomin, et al.
Publicado: (2009)

The CNDP1 (CTG)(5) Polymorphism Is Associated with Biopsy-Proven Diabetic Nephropathy, Time on Hemodialysis, and Diabetes Duration
por: Albrecht, Thomas, et al.
Publicado: (2017)

N-Glycosylation of Carnosinase Influences Protein Secretion and Enzyme Activity: Implications for Hyperglycemia
por: Riedl, Eva, et al.
Publicado: (2010)

Plasma Growth Differentiation Factor-15 Independently Predicts All-Cause and Cardiovascular Mortality As Well As Deterioration of Kidney Function in Type 1 Diabetic Patients With Nephropathy
por: Lajer, Maria, et al.
Publicado: (2010)

Carnosinases, Their Substrates and Diseases
por: Bellia, Francesco, et al.
Publicado: (2014)

A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients With Diabetic Nephropathy
por: Alkhalaf, Alaa, et al.
Publicado: (2010)

Association of CTG repeat polymorphism in carnosine dipeptidase 1 (CNDP1) gene with diabetic nephropathy in north Indians
por: Yadav, Ashok K., et al.
Publicado: (2016)

Correlation between serum carnosinase concentration and renal damage in diabetic nephropathy patients
por: Zhou, Zhou, et al.
Publicado: (2021)

The CTGF -945GC polymorphism is not associated with plasma CTGF and does not predict nephropathy or outcome in type 1 diabetes
por: Dendooven, Amélie, et al.
Publicado: (2011)

Allosteric inhibition of carnosinase (CN1) by inducing a conformational shift
por: Peters, Verena, et al.
Publicado: (2017)

Multicentric Validation of Proteomic Biomarkers in Urine Specific for Diabetic Nephropathy
por: Alkhalaf, Alaa, et al.
Publicado: (2010)

Monoclonal Antibody RYSK173 Recognizes the Dinuclear Zn Center of Serum Carnosinase 1 (CN-1): Possible Consequences of Zn Binding for CN-1 Recognition by RYSK173
por: Zhang, Shiqi, et al.
Publicado: (2016)

Serum and urinary carnosinase-1 correlate with kidney function and inflammation
por: Zhang, Shiqi, et al.
Publicado: (2022)

Binding Modes of Carnostatine, Homocarnosine, and Ophidine to Human Carnosinase 1
por: Toviwek, Borvornwat, et al.
Publicado: (2023)

Correction: Monoclonal Antibody RYSK173 Recognizes the Dinuclear Zn Center of Serum Carnosinase 1 (CN-1): Possible Consequences of Zn Binding for CN-1 Recognition by RYSK173
por: Zhang, Shiqi, et al.
Publicado: (2017)

The Influence of a Single Nucleotide Polymorphism within CNDP1 on Susceptibility to Diabetic Nephropathy in Japanese Women with Type 2 Diabetes
por: Kurashige, Mahiro, et al.
Publicado: (2013)

The (CTG)(n) repeat polymorphism in CNDP1 gene: new insights into an old molecule
por: Santos, Kátia G.
Publicado: (2016)

Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study
por: Nin, J. W. M., et al.
Publicado: (2012)

Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study
por: Peeters, S. A., et al.
Publicado: (2017)

CNDP1, NOS3, and MnSOD Polymorphisms as Risk Factors for Diabetic Nephropathy among Type 2 Diabetic Patients in Malaysia
por: Yahya, Mohd Jokha, et al.
Publicado: (2019)

Genetic Examination of SETD7 and SUV39H1/H2 Methyltransferases and the Risk of Diabetes Complications in Patients With Type 1 Diabetes
por: Syreeni, Anna, et al.
Publicado: (2011)

Faecal biomarkers in type 1 diabetes with and without diabetic nephropathy
por: Winther, Signe Abitz, et al.
Publicado: (2021)

Brain type carnosinase in dementia: a pilot study
por: Balion, Cynthia M, et al.
Publicado: (2007)

Erythrocytes Prevent Degradation of Carnosine by Human Serum Carnosinase
por: Oppermann, Henry, et al.
Publicado: (2021)

Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy
por: Skupien, Jan, et al.
Publicado: (2019)

Human carnosinase 1 overexpression aggravates diabetes and renal impairment in BTBR(Ob/Ob) mice
por: Qiu, Jiedong, et al.
Publicado: (2020)

Up-regulation of CNDP2 facilitates the proliferation of colon cancer
por: Xue, Conglong, et al.
Publicado: (2014)

Acute balenine supplementation in humans as a natural carnosinase-resistant alternative to carnosine
por: de Jager, Sarah, et al.
Publicado: (2023)

Soluble receptor for AGE in diabetic nephropathy and its progression in Finnish individuals with type 1 diabetes
por: Wadén, Jenny M., et al.
Publicado: (2019)

Higher Plasma Levels of Advanced Glycation End Products Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-year follow-up study
por: Nin, Johanna W., et al.
Publicado: (2011)

Carnosinase-1 Knock-Out Reduces Kidney Fibrosis in Type-1 Diabetic Mice on High Fat Diet
por: Pfeffer, Tilman, et al.
Publicado: (2023)

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients
por: Nielsen, Stine Elkjaer, et al.
Publicado: (2010)

The impact of diabetic nephropathy and severe diabetic retinopathy on chronic limb threatening ischemia risk in individuals with type 1 diabetes: a nationwide, population study
por: Harjutsalo, Valma, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k5b1bcap5pgshvgv6gfe4s3h66